Search Results - "Morokuma, Futoshi"

Effectiveness and safety of radium‐223 dichloride in patients with castration‐resistant prostate cancer and bone metastases in real‐world practice: A multi‐institutional study by Matsumoto, Takashi, Hori, Yoshifumi, Shiota, Masaki, Blas, Leandro, Nakamura, Motonobu, Seki, Narihito, Kuroiwa, Kentaro, Yokomizo, Akira, Morokuma, Futoshi, Kiyoshima, Keijiro, Eto, Masatoshi

“…Objective Radium‐223 (Ra‐223) dichloride is the bone‐targeted radioligand therapy that prolongs overall survival (OS) in patients with bone‐metastatic…”
Get full text

The Risk Factors of Febrile Urinary Tract Infection After Ureterorenoscopic Lithotripsy by Morokuma, Futoshi, Sadashima, Eiji, Chikamatsu, Soutaro, Nakamura, Tomoya, Hayakawa, Yusuke, Tokuda, Noriaki

“…We aimed to evaluate the risk factors for febrile urinary tract infection (fUTI) following ureterorenoscopic lithotripsy (URSL) for upper urinary tract stones…”
Get full text

Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma by Furubayashi, Nobuki, Hori, Yoshifumi, Morokuma, Futoshi, Tomoda, Toshihisa, Negishi, Takahito, Inoue, Tomohiro, Kumagai, Masatoshi, Kuroiwa, Kentaro, Tokuda, Noriaki, Nakamura, Motonobu

“…Pembrolizumab has been available for the treatment of radical resectable urothelial carcinoma (UC) when it is exacerbated after chemotherapy since December…”
Get full text

Ureterosciatic hernia successfully treated by ureteral stent placement by Sugimoto, Masaaki, Iwai, Hidenori, Kobayashi, Takeshi, Morokuma, Futoshi, Kanou, Takehiro, Tokuda, Noriaki

“…A 76‐year‐old woman with history of cholecystectomy, hysterectomy, and vesicourethral suspension presented with acute lumbar backache and discomfort in the…”
Get full text

Primary synovial sarcoma of the kidney: Report of a case confirmed by molecular detection of the SYT‐SSX2 fusion transcripts by Koyama, Shune, Morimitsu, Yosuke, Morokuma, Futoshi, Hashimoto, Hiroshi

“…We describe an unusual case of primary synovial sarcoma of the kidney. A 47‐year‐old woman had a tumor massively replacing the right kidney. There were no…”
Get full text

Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study by Furubayashi, Nobuki, Morokuma, Futoshi, Tomoda, Toshihisa, Hori, Yoshifumi, Negishi, Takahito, Miura, Akihiro, Komori, Hiroki, Kuroiwa, Kentaro, Nakamura, Motonobu

“…The optimal timing of switching from platinum-based chemotherapy to pembrolizumab in patients with advanced urothelial carcinoma (UC) remains unclear…”
Get full text

Bone-modifying agents are protective for symptomatic skeletal events in Radium-223 treatment by Blas, Leandro, Shiota, Masaki, Matsumoto, Takashi, Hori, Yoshifumi, Nakamura, Motonobu, Seki, Narihito, Kuroiwa, Kentaro, Yokomizo, Akira, Morokuma, Futoshi, Kiyoshima, Keijiro, Eto, Masatoshi

“…Radium-223 (Ra-223) dichloride therapy increases overall survival and delays time to the first symptomatic skeletal event (SSE) in patients with…”
Get full text

Randomized controlled trial of GnRH antagonist monotherapy versus GnRH agonist plus bicalutamide (CAB) for patients with metastatic hormone-sensitive prostate cancer (mHSPC) (KYUCOG-1401) by Yokomizo, Akira, Morokuma, Futoshi, Eto, Masatoshi, Shiota, Masaki, Matsuyama, Hideyasu, Matsumoto, Hiroaki, Kamoto, Toshiyuki, Terada, Naoki, Kawahara, Kazuya, Enokida, Hideki, Tatarano, Shuichi, Fujimoto, Naohiro, Higasijima, Katsuyoshi, Sakai, Hideki, Hakariya, Tomoaki, Igawa, Tsukasa, Suekane, Shigetaka, Kamba, Tomomi, Sugiyama, Yutaka, Naito, Seiji

“…Abstract only 99 Background: To investigate a clinical response of GnRH antagonist monotherapy against CAB therapy for mHSPC. Methods: Histopathological…”
Get full text

Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy by FURUBAYASHI, NOBUKI, NEGISHI, TAKAHITO, SAKAMOTO, NAOTAKA, TAMURA, SHINGO, MOROKUMA, FUTOSHI, SONG, YOOHYUN, HORI, YOSHIFUMI, TOMODA, TOSHIHISA, SEKI, NARIHITO, KUROIWA, KENTARO, NAKAMURA, MOTONOBU

“…BACKGROUND/AIMDespite the presence of a mixed response (MR) in patients with urothelial carcinoma (UC) who receive immune checkpoint inhibitors, the clinical…”
Get full text

GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone‐sensitive prostate cancer; KYUCOG‐1401 by Yokomizo, Akira, Shiota, Masaki, Morokuma, Futoshi, Eto, Masatoshi, Matsuyama, Hideyasu, Matsumoto, Hiroaki, Kamoto, Toshiyuki, Terada, Naoki, Kawahara, Kazuya, Enokida, Hideki, Tatarano, Shuichi, Fujimoto, Naohiro, Higasijima, Katsuyoshi, Sakai, Hideki, Hakariya, Tomoaki, Igawa, Tsukasa, Suekane, Shigetaka, Kamba, Tomomi, Sugiyama, Yutaka, Kishimoto, Junji, Naito, Seiji

“…Objectives To compare the effectiveness and safety of gonadotropin‐releasing hormone (GnRH) antagonist monotherapy to combined androgen blockade (CAB) with a…”
Get full text

Use of increasing the number of biopsy cores in proportion to prostate size on prostate cancer diagnosis by Morokuma, Futoshi, Sadashima, Eiji, Chikamatsu, Soutaro, Nakamura, Tomoya, Hayakawa, Yusuke, Tokuda, Noriaki

“…Objectives: This study aimed to determine the value of changing the number of biopsy cores in proportion to the size of the prostate in patients who had…”
Get full text

Treating Japanese Patients With Pembrolizumab for Platinum-Refractory Advanced Urothelial Carcinoma in Real-World Clinical Practice by Furubayashi, Nobuki, Kuroiwa, Kentaro, Tokuda, Noriaki, Tomoda, Toshihisa, Morokuma, Futoshi, Hori, Yoshifumi, Negishi, Takahito, Inoue, Tomohiro, Kumagai, Masatoshi, Nakamura, Motonobu

“…Since December 2017, pembrolizumab has been approved in Japan as a second-line treatment for radical unresectable urothelial carcinoma (UC) that has become…”
Get full text

Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy by Furubayashi, Nobuki, Negishi, Takahito, Sakamoto, Naotaka, Shimokawa, Hozumi, Morokuma, Futoshi, Song, Yoohyun, Hori, Yoshifumi, Tomoda, Toshihisa, Tokuda, Noriaki, Seki, Narihito, Kuroiwa, Kentaro, Nakamura, Motonobu

“…To evaluate the organ-specific therapeutic effect of pembrolizumab after the failure of platinum-based chemotherapy for advanced urothelial carcinoma (UC)…”
Get full text

Ureterosciatic hernia successfully treated by ureteral stent placement by Sugimoto, Masaaki, Iwai, Hidenori, Kobayashi, Takeshi, Morokuma, Futoshi, Kanou, Takehiro, Tokuda, Noriaki

Get full text

Primary synovial sarcoma of the kidney: Report of a case confirmed by molecular detection of the SYT-SSX2 fusion transcripts by Koyama, Shune, Morimitsu, Yosuke, Morokuma, Futoshi, Hashimoto, Hiroshi

Get full text